isocoumarins has been researched along with Cancer of Esophagus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beckett, MA; Gupta, VK; Hari, DM; Hellman, S; Jaskowiak, NT; Kalluri, R; Koons, AM; Kufe, DW; Mauceri, HJ; Posner, MC; Reimer, C; Salloum, RM; Seetharam, S; Weichselbaum, RR | 1 |
1 other study(ies) available for isocoumarins and Cancer of Esophagus
Article | Year |
---|---|
NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity.
Topics: Adenocarcinoma; Animals; Carcinoma, Lewis Lung; Cell Movement; Cells, Cultured; Collagen; Coumarins; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Combinations; Endothelium, Vascular; Esophageal Neoplasms; Female; Humans; Isocoumarins; Laminin; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Neoplasms; Proteoglycans; Radiation, Ionizing; Time Factors; Tumor Cells, Cultured; Umbilical Veins | 2000 |